Fundz

Wearable Medical Devices Company Acurable Raises €11M In Series A Funding Round

PRIVATEOct 03, 2022

Amount Raised

€11 Million

Round Type

Series A

BiotechnologyHealth CareMedicalMedical Device

Description

Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a result of its Series A funding round. These funds will be used to accelerate the international expansion of its first product AcuPebble SA100 and drive the company towards its ambition to become the preferred solution for home sleep testing worldwide. The investment was led by Kibo Ventures, along with Mundi Ventures, Kindred Capital, and Comprador Holdings among others.

Quick answer

Acurable raised €11 Million in a Series A round, dated October 3, 2022.

How much did Acurable raise?
Acurable raised €11 Million in a Series A round on October 3, 2022.
What does Acurable do?
Acurable is a fast growing MedTech company headquartered in London.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Acurable that raised within 45 days of this round, from Fundz verified event records.

  • Biocoat raised an undisclosed amount on November 2, 2022.
  • Nusano raised $10M on November 1, 2022.
  • Lazzaro Medical raised $1M (Seed) on October 27, 2022.
  • Monteris Medical raised $73M (Debt Financing) on October 27, 2022.
  • Adagio Medical raised $9.5M on October 27, 2022.
  • DeepUll raised $13M (Series B) on October 20, 2022.

Who to call at Acurable, and when

A new round usually means Acurable is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Acurable raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acurable, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acurable. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acurable

About

Acurable is a fast growing MedTech company headquartered in London. We produce the first wearable medical device able to accurately diagnose and manage respiratory conditions at home. Our award-winning patented technology is a major engineering innovation and the product of over 10 years research at Imperial College London. - Accurate : 5x more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis. - Easy to use : non-invasive and no training required, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs. We aim to understand human biosignals so well that nobody dies of a treatable condition ever again. To achieve our objectives, we are building a team of exceptional people who are inspired by our vision, share our values, and who have the attitude and skills required to help Acurable succeed.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acurable raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Acurable's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Acurable raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.